Veranova Appoints Cécile Maupas as Senior Vice President, Chief Commercial Officer

July 17, 2024

Wayne, PA Veranova, a global leader in the development and manufacturing of specialist and complex APIs for the pharmaceutical and biotech sectors, is pleased to announce the appointment of Cécile Maupas as Senior Vice President, Chief Commercial Officer. Cécile will join the executive team and assume responsibility for business development, marketing, project management, commercial operations, and product management.

Cécile Maupas

The news comes after Veranova recently announced expansion – estimated at $30 million – of its antibody-drug conjugate (ADC) and highly potent compound development and manufacturing capabilities at its Devens, MA facility.

A seasoned commercial and business executive, Cécile brings a deep understanding of contract development and manufacturing organizations (CDMO) and the pharmaceutical industry. Her proven track record of building teams and transforming organizations and extensive experience across multiple drug modalities will ensure Cécile is an integral part of Veranova’s continued growth.

After obtaining a B.A. and a Masters in Biochemistry from the University of Paris, Cécile started her career as a Sales Manager at GE Healthcare Life Sciences, progressing in commercial roles of increasing responsibility with the company over 10 years. She subsequently helped develop and scale the biopharma CDMO business at Novasep, focusing on monoclonal antibodies, ADCs and viral vectors. More recently, Cécile was Head of CDMO Business Development at Pierre Fabre focusing on biotech drug substances including ADC and drug products and then joined Sanofi Active Ingredient Solutions in 2020 as Head of CDMO and Business Scouting to develop the business in complex small molecules, peptides, oligonucleotides, HPAPI and particle engineering. In addition, she has served on the executive committee of EuroAPI as Chief CDMO Officer.

“I’m delighted to have Cécile join the Veranova team as our Chief Commercial Officer” said Mike Riley, Chief Executive Officer of Veranova. “Her expertise and track record in building and growing businesses will be invaluable as Veranova continues to execute our strategy to build a world-class CDMO.”

Veranova welcomes Cécile and looks forward to working alongside her as the company continues to advance its global strategy and deliver excellence for both partners and patients.

 

About Veranova

Veranova is a global leader in process development and the manufacturing of APIs, with a focus on specialty and complex products. Veranova is headquartered in Wayne, PA and has operations in North America and Europe.

Contact Details

For further information and interview opportunities with Veranova, please contact:

Charles Ben-Cofie
Senior Content Manager, Notch Communications
T: +44 (0) 161 457 7230
E: Charles.ben-cofie@notchcommunications.co.uk

 

Veranova is your next great decision

Discover new ways to advance your science with Veranova.

Contact us